Related Experiment Video
Updated: May 12, 2026

The Corneal Micropocket Assay: A Model of Angiogenesis in the Mouse Eye
Published on: August 17, 2014
Evaluation of intrastromal micropuncture in Eye Bank corneas using a tattoo machine
Michelle de Lima Farah1, Samir Arbache2, Rubens Belfort1,3
1Department of Ophthalmology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Purpose:
To assess the reliability and penetration depth of an automated micropuncture system using a tattoo machine.
Methods:
Twenty human corneas were obtained and subjected to intrastromal micropuncture using a tattoo machine. Each cornea was divided into two halves: one received pigment, while the other received saline solution as a control. The Cheyenne tattoo machine was operated at 60 Hz, with standardized needle exposure (six passes per application). The machine used cartridges containing five microneedles. The study was registered with Agência Nacional de Vigilância Sanitária ANVISA (numbers 80281110015, 80281110016, and 80281110019). The pigment used was Electric Ink black ink, with a density of 1,271,460 μg/mL. Puncture depth was measured before and after the procedure using both anterior segment optical coherence tomography and histopathological analysis. Puncture depth measurements were analyzed using ImageJ software. Each cornea was measured thrice, and the results were subsequently compared.
Results:
No corneal perforations were observed with the use of the tattoo machine, and puncture depth measurements ranged from 107 to 486 μm.
Conclusions:
The use of a tattoo machine represents a viable and accessible approach for keratopigmentation, with potential for both cosmetic and therapeutic applications. Its adaptation for controlled intrastromal drug delivery may enable the targeted treatment of deep infectious keratitis, corneal neovascularization, and stromal inflammatory disorders, representing a promising approach for corneal stromal diseases. Further research is needed to optimize techniques and evaluate long-term safety and efficacy, particularly for the delivery of antimicrobial, anti-inflammatory, and anti-vascular endothelial growth factor agents.

